$9.94
+2.1%Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.
Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.
Capital-intensive operations require significant reinvestment. Monitor whether CapEx is maintenance or growth-oriented.
Declining FCF warrants attention. Investigate whether due to temporary factors or fundamental deterioration.
Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extensionโmonitor closely.
Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.
VREX โข NASDAQ
| Varex Imaging Corporation Cash Flow Statement | Oct 2025 | Sep 2024 | Sep 2024 | Sep 2023 | Sep 2023 | Sep 2022 | Oct 2021 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||||||
-69.9M | -47.2M | -47.2M | 48.7M | 48.7M | 30.8M | 17.9M | 17.9M | -57.4M | 15.8M | 28.3M | 52M | 69M | 80.8M | 110.1M | 109.6M | |
27.2M | 31.1M | 31.1M | 33.2M | 33.2M | 33.6M | 37.3M | 37.3M | 39.5M | 39.2M | 42.2M | 27.4M | 15.3M | 12.3M | 10.1M | 10.1M | |
-500K | 37M | 37M | -39.5M | -39.5M | 600K | -3M | -3M | -3.1M | -12.9M | -7.7M | -8.9M | 4.2M | -800K | -1.5M | -1.6M | |
15M | 15.3M | 15.3M | 13.5M | 13.5M | 14M | 13.9M | 13.9M | 13.4M | 11.7M | 10M | 8.4M | 9.5M | 9.6M | 8M | 9.8M | |
101.3M | 9.1M | 9.1M | 29.2M | 29.2M | 25.9M | 18.3M | 18.3M | 34.7M | 13.4M | 6.5M | 2.3M | 2.4M | -1.6M | 100K | -5.7M | |
(18.6M) | (20.2M) | (20.2M) | (16.7M) | (16.7M) | (2.2M) | (14.1M) | (14.1M) | (4.2M) | (8.2M) | (13.8M) | (6M) | (0.0) | (0.0) | (0.0) | (0.0) | |
-31.4M | 2M | 2M | 23.3M | 23.3M | -88M | 8.2M | 8.2M | -13.9M | 4.7M | 6M | -6.6M | -26.2M | -15.1M | -8.2M | -31M | |
41.7M | 47.3M | 47.3M | 108.4M | 108.4M | 16.9M | 92.6M | 92.6M | 13.2M | 71.9M | 85.3M | 74.6M | 74.2M | 85.2M | 118.6M | 91.2M | |
INVESTING ACTIVITIES | ||||||||||||||||
-22.9M | -26.9M | -26.9M | -20.7M | -20.7M | -21.3M | -15.1M | -15.1M | -23.5M | -19.8M | -20.4M | -20.2M | -28.9M | -34.3M | -23.2M | -8.3M | |
(0.0) | (900K) | (900K) | -1M | -1M | (1.1M) | -1.4M | -1.4M | -3.4M | -73.4M | -4.8M | -271.8M | -1.2M | -67.9M | -5.4M | (0.0) | |
-31.4M | -61M | -61M | -55.9M | -55.9M | -28.3M | (0.0) | (0.0) | -1.8M | -3.9M | -600K | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
65.4M | 60.6M | 60.6M | 28.3M | 28.3M | 2M | 0.0 | 0.0 | 5.2M | 77.3M | 0.0 | 0.0 | 8.6M | 0.0 | 0.0 | 0.0 | |
-800K | -1.1M | -1.1M | 4.4M | 4.4M | -1.9M | 300K | 300K | -3.4M | -73.4M | -600K | 0.0 | -100K | 100K | 0.0 | 0.0 | |
(10.3M) | -27.5M | -27.5M | -44.9M | -44.9M | -48.4M | -16.2M | -16.2M | -26.9M | -93.2M | -25.8M | -292M | -21.6M | -102.1M | -28.6M | -8.3M | |
FINANCING ACTIVITIES | ||||||||||||||||
3.3M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.8M | 0.0 | 7.1M | -1.9M | 0.0 | 0.0 | 0.0 | 0.0 | |
-75M | -1.6M | -1.6M | -2.4M | -2.4M | -29.4M | -31.6M | -31.6M | 109.9M | -1.6M | -96M | 494M | 0.0 | 0.0 | 0.0 | 0.0 | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -500K | -600K | -227.1M | (0.0) | (0.0) | (0.0) | (0.0) | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -2.1M | -2.3M | -1.9M | (0.0) | (0.0) | (0.0) | (0.0) | |
-4.2M | -1.7M | -1.7M | 2.2M | 2.2M | 5.6M | -700K | -700K | -24.5M | 2M | -900K | -1.7M | -36.8M | 36.7M | -89.9M | -83.3M | |
-75.9M | -3.3M | -3.3M | -200K | -200K | -23.8M | -32.3M | -32.3M | 83.6M | -100K | -90.4M | 263.3M | -36.8M | 36.7M | -89.9M | -83.3M | |
CASH FLOW SUMMARY | ||||||||||||||||
600K | -100K | -100K | 100K | 100K | -200K | -100K | -100K | 900K | -700K | -500K | 900K | 100K | 300K | 0.0 | 0.0 | |
-23.3M | 16.4M | 16.4M | 63.4M | 63.4M | -55.5M | 44M | 44M | 70.8M | -22.1M | -31.4M | 46.8M | 15.9M | 20.1M | 100K | -400K | |
170.4M | 154M | 154M | 90.6M | 90.6M | 146.1M | 102.1M | 102.1M | 31.3M | 53.4M | 83.3M | 36.5M | 20.6M | 500K | 400K | 800K | |
147.1M | 170.4M | 170.4M | 154M | 154M | 90.6M | 146.1M | 146.1M | 102.1M | 31.3M | 51.9M | 83.3M | 36.5M | 20.6M | 500K | 400K | |
18.8M | 20.4M | 20.4M | 87.7M | 87.7M | -4.4M | 77.5M | 77.5M | -10.3M | 52.1M | 64.9M | 54.4M | 45.3M | 50.9M | 95.4M | 82.9M |
VREX - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q2 Q2 | May 07, 2026 | April 03, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 07, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 16, 2026 | March 13, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 13, 2026 | February 12, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | February 10, 2026 | January 02, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 10, 2026 | February 10, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | December 29, 2025 | February 12, 2026 | 2026 | |
10-K 10-K 2025 FY FY | November 18, 2025 | October 03, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 18, 2025 | November 18, 2025 | 2025 | |
8-K 8-K 2025 N/A | September 11, 2025 | September 05, 2025 | 2025 |
Continue your VREX research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.